The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)
Advanced Search

Session Details

Oral Presentation(E) Pharmaceutical Health Care and Sciences

[27-12-pm]Clinical Pharmacy 1, Formulation testing/In-house formulation/Management of intravenous and enteral nutrition, Others

Fri. Mar 27, 2026 3:30 PM - 5:18 PM JST
Fri. Mar 27, 2026 6:30 AM - 8:18 AM UTC
Room 12 (C403, Bldg. 2, Area 2 [4F])
Chair: Yuki Kobayashi, Takaaki Ito
3:30 PM - 3:42 PM JST(6:30 AM - 6:42 AM UTC)

[27-12-pm10S]Evaluation of the skin permeability of rivastigmine from its adhesive patches based on acrylic polymers

○Yuuki Kojima1, Yuuki Takahashi1, Noriaki Okamoto2, uramatsu shunji2, Mika Yoshimura Fujii 1, Suzuko Terayama1, Keiji Hirota1, Toshiro Fukami1 (1. Meiji Pharmaceutical University, 2. Daido Chemical Corporation)
3:42 PM - 3:54 PM JST(6:42 AM - 6:54 AM UTC)

[27-12-pm11S]Development of a cancer therapy using externally applied magnetic field and light with FePt nanoparticles synthesized under low-temperature conditions

○Rin Yamashita1, Koki Ogawa1, Tetsuya Ozeki1 (1. Grad. Sch. Pharm. Sci., Nagoya City Univ.)
3:54 PM - 4:06 PM JST(6:54 AM - 7:06 AM UTC)

[27-12-pm12S]Improved absorption by forming an amenamevir–tartaric acid cocrystal

○Naoto Arai1, Wataru kobayashi1, Nasa Sakamoto1, Keiji Hirota1, Toshiyuki Kudo2, Yoshiaki Yamagishi2, Kiyomi Ito2, Hiroki Kitagawa3, Masato Kobayashi3, Toshiro Fukami1 (1. Meiji Pharm. Univ., 2. Musashino Univ., 3. Maruho Co.,Ltd.)
4:06 PM - 4:18 PM JST(7:06 AM - 7:18 AM UTC)

[27-12-pm13]Color evaluation of drug-excipient powder mixtures using a spectrophotometer

○Yuta Hatanaka1, Keita Fujii1, Takashi Sebe2, Takayuki Terukina1, Hiromu Kondo1 (1. Sch. Pharm. Sci., Univ. Shizuoka, 2. Qualitech Pharma Co., Ltd.)
4:18 PM - 4:30 PM JST(7:18 AM - 7:30 AM UTC)

[27-12-pm14S]Chiral Pharmacokinetic Analysis and Enantiomeric Synthesis of Ritodrine, a Tocolytic Agent

○Mako Okabe1, Satoshi Kitaoka1, Saeko Kitazawa1, Satomi Kubo1, Shunsuke Nakajima1, Shiori Yuhara1, Ryo Watanabe1, Yuki Takano1, Yuya Egawa1 (1. Josai University)
4:30 PM - 4:42 PM JST(7:30 AM - 7:42 AM UTC)

[27-12-pm15]Discussion for degradation reactions of hydrocortisone in tap-water from the degradation products patterns on HPLC

○Hiroto Kawakami1, Takuro Kurita1, Kazunori Nakajima1, Tadakazu Tokumura2 (1. Nihon Pharmaceutical University, 2. Small Village)
4:42 PM - 4:54 PM JST(7:42 AM - 7:54 AM UTC)

[27-12-pm16S]Percutaneous Absorption of OTC Indomethacin Topical Formulations: Comparison with Prescription Products

○Ayame Kamata1, Michiyo Okudaira1, Nobuhiro Yasuno1,2 (1. Fac. of Pharm. Sci., Teikyo Univ., 2. Dept. of Pharm. Teikyo Univ. Hospital)
4:54 PM - 5:06 PM JST(7:54 AM - 8:06 AM UTC)

[27-12-pm17]Omalizumab Use and the Risk of Maternal Outcomes: Findings from TriNetX Global Real-World Data

○Chung-Hsuen Wu1, Chun Tse Hung2, Jen-Ai Lee3 (1. National Yang Ming Chiao Tung University, 2. University of Michigan, 3. Taipei Medical University)
5:06 PM - 5:18 PM JST(8:06 AM - 8:18 AM UTC)

[27-12-pm18S]Risk of Recurrent Diabetic Ketoacidosis After Reinitiation of Sodium–Glucose Cotransporter 2 Inhibitors

○Ming Lih1, Chien-Chih Wu1,3, Chi-Chuan Wang1,2,3, Hue-Nghi To2 (1. Sch. Pharm., Natl. Taiwan Univ., 2. Grad. Inst. Pharm., Natl. Taiwan Univ., 3. Natl. Taiwan Univ. Hosp.)
Back to Category List